...
首页> 外文期刊>Biomedicine & pharmacotherapy =: Biomedecine & pharmacotherapie >LncRNA MIR31HG overexpression serves as poor prognostic biomarker and promotes cells proliferation in lung adenocarcinoma
【24h】

LncRNA MIR31HG overexpression serves as poor prognostic biomarker and promotes cells proliferation in lung adenocarcinoma

机译:LNCRNA miR31Hg过表达作为预后较差的生物标志物,促进肺腺癌中细胞增殖

获取原文
获取原文并翻译 | 示例
           

摘要

MIR31HG, as the host gene of miR-31, has been suggested to involve in various cancer developments. However, little is known about the clinical significance and biological function of MIR31HG in lung adenocarcinoma. In our study, we found MIR31HG was highly expressed in lung adenocarcinoma tissues and cell lines, and associated with clinical staging, N classification, M classification and differentiated degree. Survival analysis showed MIR31HG high-expression was an independent unfavorable prognostic factor for lung adenocarcinoma patients. Loss-of-function studies suggested down-regulation of MIR31HG inhibited lung adenocarcinoma cells proliferation and blocked cell-cycle, but has no effect on cell apoptosis. There was no correlation between MIR31HG and miR-31 expression in lung adenocarcinoma tissues, down-regulation of MIR31HG had no effect on the expression of miR-31 in lung adenocarcinoma cells. In conclusion, MIR31HG high-expression is an independent unfavorable prognostic factor for lung adenocarcinoma patients, and serves an oncogenic role to modulate lung adenocarcinoma cells proliferation and cell-cycle.
机译:作为miR-31的宿主基因,提出了涉及各种癌症发展的MiR31Hg。但是,关于miR31hg在肺腺癌中的临床意义和生物学功能几乎熟知。在我们的研究中,我们发现MiR31HG在肺腺癌组织和细胞系中高度表达,以及临床分期,N分类,M分类和分化程度相关。存活分析显示MiR31HG高表达是肺腺癌患者的独立不利的预后因素。函数丧失研究表明MiR31HG的下调抑制肺腺癌细胞增殖和阻断细胞周期,但对细胞凋亡没有影响。 miR31Hg和miR-31在肺腺癌组织中没有相关性,mir31hg的下调对肺腺癌细胞中miR-31的表达没有影响。总之,MiR31Hg高表达是肺腺癌患者的独立不利的预后因素,并为调节肺腺癌细胞增殖和细胞循环提供致癌作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号